Tag: HLA-B*1502

By Posted on Posted in Adverse Drug Reaction [ADR], Allelic Variant, Genetic Background, Genetic Predisposition, Genetic Susceptibility, Thasso Post, Theragenomic Medicine Tagged with , , , , , , , , , ,

August 21, 2022 – Systemic lupus erythematosus (SLE) is a common, incurable autoimmune disease that affects millions of individuals worldwide, with a particularly high prevalence among women. A genetic variant, called HLA-DRB1*03:01, is the greatest risk factor for the condition, …

Serious lupus: Strong genetic risk factor on its path Read more »

By Posted on Posted in Allelische Variante, Keine Kategorie, Personalized Medicine, Pharmacogenetics, Thasso Post Tagged with , , , , , , , , , , , , ,

October 10, 2013 – Very recently, David Kerr, Professor of Cancer Medicine at University of Oxford, in the United Kingdom, and past President of the European Society for Medical Oncology, talked on Medscape (see the video here) about risk-benefit analyses …

Can We Identify Risk for Drug Toxicity? Read more »